Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 27, 2009 08:00 ET | Source: Synergy Pharmaceuticals

Callisto Pharmaceuticals Redirects Atiprimod Clinical Development to Treat Rheumatoid Arthritis

NEW YORK--Callisto Pharmaceuticals, Inc. (OTC BB: CLSP.OB) today announced that it is focusing further development of atiprimod on treatment of rheumatoid arthritis (RA). Atiprimod has demonstrated a...
December 09, 2008 13:25 ET | Source: Synergy Pharmaceuticals

Callisto Pharmaceuticals' Majority-Owned Subsidiary Synergy Pharmaceuticals Completes Phase I Trial of SP-304 in Volunteers

NEW YORK--Callisto Pharmaceuticals, Inc. (OTC BB:CLSP.OB), a developer of new drugs to treat cancer and gastrointestinal disorders, announced today that Synergy Pharmaceuticals (OTC BB: SGYP), its...
December 09, 2008 09:16 ET | Source: Synergy Pharmaceuticals

Synergy Pharmaceuticals Successfully Completes Phase I Trial of SP-304 in Volunteers

NEW YORK--Synergy Pharmaceuticals, Inc. (OTCBB: SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today the completion of the Phase I clinical trial of...
October 15, 2008 09:00 ET | Source: Synergy Pharmaceuticals

Dr. Mel Spigelman, Director of Synergy Pharmaceuticals, Appointed President and CEO of Global Alliance for TB Drug Development

NEW YORK--Synergy Pharmaceuticals, Inc. (OTC BB:SGYP.OB SGYP News) is pleased to congratulate Melvin K. Spigelman, M.D., a director of Synergy Pharmaceuticals, on his recent appointment as President...
August 27, 2008 19:02 ET | Source: Synergy Pharmaceuticals

Synergy Pharmaceuticals Announces Appointment of Dr. Mel Spigelman to Board of Directors

NEW YORK--Synergy Pharmaceuticals, Inc. (OTC BB:SGYP) is pleased to announce that on August 21, 2008, the Board of Directors of Synergy Pharmaceuticals, Inc. appointed Melvin K. Spigelman, M.D. as a...
August 11, 2008 09:59 ET | Source: Synergy Pharmaceuticals

Synergy Pharmaceuticals, Inc. Effects Name Change and Forward Stock Split

NEW YORK--Synergy Pharmaceuticals, Inc. (OTC BB: SGYP) (the "Company") (formerly Pawfect Foods, Inc.) is pleased to announce that it has changed its name to Synergy Pharmaceuticals, Inc. effective...